Company Filing History:
3 out of 377 
3 out of 574 
2 out of 526 
Years Active: 2011-2021
Title: Innovator in Cancer Treatment: Dimitar B. Nikolov
Introduction: Dimitar B. Nikolov is a prominent inventor located in New York, NY, known for his significant contributions to cancer diagnosis and treatment through innovative antibody therapies. With a portfolio comprising four patents, his work focuses on the development of advanced therapeutic agents for various malignancies.
Latest Patents: Among his latest patents, Dimitar’s innovations include an anti-metalloprotease antibody designed for the diagnosis and treatment of cancers. This invention targets the high molecular weight ADAM10 protease, which is often overexpressed in tumor cells expressing the CD133 stem cell marker. The recombinant humanized antibody, derived from the 8C7 monoclonal antibody, enables selective binding to this protease, allowing for both detection of tumor cells and therapeutic applications for cancers such as leukemia, lymphoma, lung cancer, colon cancer, neuroblastoma, and melanoma. Another significant patent encompasses methods and compositions targeting overexpressed EphA2, where an anti-EphA2 scFv single-chain antibody prevents ephrin binding to EphA2. This invention has potential applications in combination therapies, including the linking of other antigen-targeting domains or conjugation with toxins to enhance treatment efficacy.
Career Highlights: Dimitar B. Nikolov has significantly impacted cancer research and treatment through his tenure at prestigious institutions, including Monash University and Memorial Sloan Kettering Cancer Center. His groundbreaking work has advanced understanding and treatment options available for various cancers, contributing to the evolving landscape of cancer therapy.
Collaborations: Throughout his career, Nikolov has collaborated with notable experts in the field, including Martin Lackmann and Peter W. Janes. Their collective expertise has enriched the research and development of innovative therapeutic strategies, further underscoring the collaborative nature of scientific advancements.
Conclusion: Dimitar B. Nikolov stands out as an inspiring inventor whose work is crucial in the fight against cancer. Through his innovative patents and collaborations, he continues to pave the way for new diagnostic and therapeutic avenues, ultimately striving to improve patient outcomes in oncology. His dedication to research reflects a commitment to revolutionizing treatment modalities and enhancing our understanding of complex diseases.